Knowledge and Opinion on Cannabinoids Among Orthopaedic Traumatologists

J Am Acad Orthop Surg Glob Res Rev. 2021 Apr 19;5(4):e21.00047. doi: 10.5435/JAAOSGlobal-D-21-00047.


Introduction: Cannabinoids are an increasingly popular therapy among orthopaedic patients for musculoskeletal conditions. A paucity of evidence to support their use in orthopaedics exists, likely because of the incongruence of federal and state legalization and the stigma surrounding cannabis. The purpose of this study is to elucidate sentiments and knowledge base of the orthopaedic trauma community with regard to cannabinoid-containing compounds.

Methods: A 21-question online survey was distributed to the members of the Orthopaedic Trauma Association with a response window of 3 months.

Results: We evaluated 251 responses. Most (88%) of the respondents did not believe that they were knowledgeable about the mechanism of action of cannabis/cannabidiol (CBD) but did feel that cannabis or CBD products play a role in managing postoperative pain (73%). Most respondents did not believe that they would be stigmatized if they suggested CBD (83%) or cannabis (67%) to patients. Despite this, fewer respondents have suggested CBD (38%) or cannabis (29%) to their patients.

Conclusions: Sentiment toward cannabinoids among orthopaedic traumatologists is remarkably favorable; however, in-depth understanding is admittedly poor and routine use is uncommon. More clinical research for cannabinoids is needed to help orthopaedic traumatologists provide guidance for patients seeking advice for this recently popular therapeutic.

MeSH terms

  • Cannabidiol*
  • Cannabinoids*
  • Cannabis*
  • Hallucinogens*
  • Humans
  • Orthopedics*


  • Cannabinoids
  • Hallucinogens
  • Cannabidiol